S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   271.39 (+2.34%)
AAPL   451.84 (+3.28%)
MSFT   208.65 (+2.59%)
FB   259.42 (+1.28%)
GOOGL   1,507.25 (+1.80%)
AMZN   3,160.57 (+2.59%)
NVDA   457.50 (+5.41%)
CGC   17.24 (+1.71%)
BABA   254.89 (+2.60%)
TSLA   1,557.10 (+13.29%)
GE   6.70 (-0.45%)
MU   48.40 (+1.34%)
AMD   82.69 (+7.56%)
T   30.17 (-0.10%)
F   7.10 (-1.80%)
ACB   9.80 (-2.20%)
GILD   68.71 (+0.90%)
NFLX   474.60 (+1.64%)
DIS   131.53 (+0.80%)
BAC   26.75 (-0.63%)
BA   175.47 (-2.59%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   271.39 (+2.34%)
AAPL   451.84 (+3.28%)
MSFT   208.65 (+2.59%)
FB   259.42 (+1.28%)
GOOGL   1,507.25 (+1.80%)
AMZN   3,160.57 (+2.59%)
NVDA   457.50 (+5.41%)
CGC   17.24 (+1.71%)
BABA   254.89 (+2.60%)
TSLA   1,557.10 (+13.29%)
GE   6.70 (-0.45%)
MU   48.40 (+1.34%)
AMD   82.69 (+7.56%)
T   30.17 (-0.10%)
F   7.10 (-1.80%)
ACB   9.80 (-2.20%)
GILD   68.71 (+0.90%)
NFLX   474.60 (+1.64%)
DIS   131.53 (+0.80%)
BAC   26.75 (-0.63%)
BA   175.47 (-2.59%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   271.39 (+2.34%)
AAPL   451.84 (+3.28%)
MSFT   208.65 (+2.59%)
FB   259.42 (+1.28%)
GOOGL   1,507.25 (+1.80%)
AMZN   3,160.57 (+2.59%)
NVDA   457.50 (+5.41%)
CGC   17.24 (+1.71%)
BABA   254.89 (+2.60%)
TSLA   1,557.10 (+13.29%)
GE   6.70 (-0.45%)
MU   48.40 (+1.34%)
AMD   82.69 (+7.56%)
T   30.17 (-0.10%)
F   7.10 (-1.80%)
ACB   9.80 (-2.20%)
GILD   68.71 (+0.90%)
NFLX   474.60 (+1.64%)
DIS   131.53 (+0.80%)
BAC   26.75 (-0.63%)
BA   175.47 (-2.59%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   271.39 (+2.34%)
AAPL   451.84 (+3.28%)
MSFT   208.65 (+2.59%)
FB   259.42 (+1.28%)
GOOGL   1,507.25 (+1.80%)
AMZN   3,160.57 (+2.59%)
NVDA   457.50 (+5.41%)
CGC   17.24 (+1.71%)
BABA   254.89 (+2.60%)
TSLA   1,557.10 (+13.29%)
GE   6.70 (-0.45%)
MU   48.40 (+1.34%)
AMD   82.69 (+7.56%)
T   30.17 (-0.10%)
F   7.10 (-1.80%)
ACB   9.80 (-2.20%)
GILD   68.71 (+0.90%)
NFLX   474.60 (+1.64%)
DIS   131.53 (+0.80%)
BAC   26.75 (-0.63%)
BA   175.47 (-2.59%)
Log in

ASX:CLVClover Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
A$2.13
MA: A$2.13▼
A$2.13
52-Week Range N/A
Volume210,197 shs
Average Volume127,440 shs
Market Capitalization$354.24 million
P/E Ratio34.92
Dividend Yield1.06%
BetaN/A
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. The company was founded in 1988 and is headquartered in Altona North, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.77 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolASX:CLV
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.clovercorp.com.au
Phone+61-3-83475000

Debt

Debt-to-Equity Ratio32.26
Current Ratio4.92
Quick Ratio1.32

Price-To-Earnings

Trailing P/E Ratio34.92
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$80.04 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow-2,130.00
Book ValueA$0.30 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees39
Outstanding Shares166,310,000
Market Cap$354.24 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CLV News and Ratings via Email

Sign-up to receive the latest news and ratings for CLV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Clover (ASX:CLV) Frequently Asked Questions

How were Clover's earnings last quarter?

Clover Co. Limited (ASX:CLV) announced its earnings results on Wednesday, March, 21st. The company reported $0.02 EPS for the quarter.
View Clover's earnings history.

How often does Clover pay dividends? What is the dividend yield for Clover?

Clover declared a Final dividend on Monday, September 23rd. Stockholders of record on Wednesday, November 20th will be paid a dividend of 0.018 per share on Wednesday, November 20th. This represents a dividend yield of 0.64%. The ex-dividend date is Tuesday, October 29th.
View Clover's dividend history.

Has Clover been receiving favorable news coverage?

Media coverage about CLV stock has been trending negative this week, InfoTrie reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Clover earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.
View the latest news about Clover.

Who are some of Clover's key competitors?

Some companies that are related to Clover include Advanced Medical Solutions Group (AMS), Retractable Technologies (RVP), InfuSystem (INFU), CRH Medical (CRH), Bovie Medical (BVX), Tristel (TSTL), CRH Medical (CRHM), CRH Medical (CRHM), Omega Diagnostics Group (ODX), Milestone Scientific (MLSS), SDI (SDI), Daxor (DXR), Daxor (DXR), IsoRay (ISR) and IsoRay (ISR).
View all competitors.

What other stocks do shareholders of Clover own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clover investors own include South32 (S32), ServiceNow (NOW), Broadcom (AVGO), Advanced Micro Devices (AMD), American Express (AXP), salesforce.com (CRM), Cisco Systems (CSCO), Dropbox (DBX), Enterprise Products Partners (EPD) and Intel (INTC).

Who are Clover's key executives?

Clover's management team includes the following people:
  • Mr. Peter J. Davey MBA, gradDip Bus., GAICD, CEO, MD & Exec. Director
  • Mr. Paul A. Sherman C.A., M.B.A., B.Bus, CA, MBA, CFO & Company Sec.
  • Mr. David Pierotti, Operations Mang.
  • Dr. C. Patch, Chief Innovation Officer
  • S. Poothong, Chief Commercial Officer

What is Clover's stock symbol?

Clover trades on the ASX under the ticker symbol "CLV."

How big of a company is Clover?

Clover has a market capitalization of $0.00 and generates $80.04 million in revenue each year. Clover employs 39 workers across the globe.

What is Clover's official website?

The official website for Clover is www.clovercorp.com.au.

How can I contact Clover?

Clover's mailing address is U 35E 1 International Dr, MELBOURNE, VIC 3049, Australia. The company can be reached via phone at +61-3-83475000.

This page was last updated on 8/12/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.